Skin infections and antibiotic prescribing: A comparison of surveillance and prescribing data

British Journal of General Practice

Volumn 57, Issue 540, 2007, Pages 569-573

  Fleming, Douglas M ^a   Elliot, Alex J ^a   Kendall, Helen ^b  

^a ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

^b Pharmaceutical Policy and Services   (United Kingdom)

Author keywords

Flucloxacillin; Fusidic acid; Mupirocin; Sentinel surveillance; Skin infections

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; ERYTHROMYCIN; FLUCLOXACILLIN; FUSIDIC ACID; PSEUDOMONIC ACID;

ADOLESCENT; ARTICLE; AUTUMN; CHILD; CONTROLLED STUDY; DRUG USE; EPIDEMIOLOGICAL DATA; GENERAL PRACTICE; HEALTH SURVEY; HUMAN; IMPETIGO; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MEDICAL RECORD; PHYSICIAN ATTITUDE; POPULATION RESEARCH; PRESCRIPTION; SKIN INFECTION; SUMMER; UNITED KINGDOM; WINTER;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; ENGLAND; FAMILY PRACTICE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; SKIN DISEASES, BACTERIAL; WALES;

EID: 34447249327     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Fleming DM, Ross AM, Cross KW, Kendall H. The reducing incidence of respiratory tract infection and its relation to antibiotic prescribing. Br J Gen Pract 2003; 53(495): 778-783.
2. Ashworth M, Charlton J, Ballard K, et al. Variations in antibiotic prescribing and consultation rates for acute respiratory infection in UK general practices 1995-2000. Br J Gen Pract 2005; 55(517): 603-608.
3. Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA 1998; 279(11): 875-877.
4. McCormick A, Fleming D, Charlton J. Morbidity statistics from general practice. Fourth National Study 1991-1992. London: HMSO, 1995.
5. Bruijnzeels MA, Foets M, van der Wouden JC, et al. Everyday symptoms in childhood: occurrence and general practitioner consultation rates. Br J Gen Pract 1998; 48(426): 880-884.
6. RCGP Birmingham Research Unit. Weekly Returns Service annual report. Birmingham: Royal College of General Practitioners, 2003.
7. RCGP Birmingham Research Unit. Weekly Returns Service annual prevalence report. 2004. Royal College of General Practitioners. http://www.rcgp.org.uk/bru_/bru_home/annual_prevalence.aspx (accessed 21 May 2007).
8. Mohammedamin RS, van der Wouden JC, Koning S, et al. Increasing incidence of skin disorders in children? A comparison between 1987 and 2001. BMC Dermatol 2006; 6: 4.
9. Loffeld A, Davies P, Lewis A, Moss C. Seasonal occurrence of impetigo: a retrospective 8-year review (1996-2003). Clin Exp Dermatol 2005; 30(5): 512-514.
10. Elliot AJ, Cross KW, Smith GE, et al. The association between impetigo, insect bites and air temperature a retrospective 5-year study (1999-2003) using morbidity data collected from a sentinel general practice network database. Fam Pract 2006; 23(5): 490-496.
11. Koning S, Verhagen AP, van Suijlekom-Smit LW, et al. Interventions for impetigo. Cochrane Database Syst Rev 2004: CD003261.
12. Resnick SD. Staphylococcal and streptococcal skin infections: pyodermas and toxin-mediated syndromes. In: Harper JI, Oranje AP, Prose NS, (eds). Textbook of pediatric dermatology. Oxford: Blackwell Science, 2000: 369-383.
13. Brown EM, Wise R. Fusidic acid cream for impetigo. Fusidic acid should be used with restraint. BMJ 2002; 324(7350): 1394.
14. Owen SE, Cheesbrough JS. Fusidic acid cream for impetigo. Findings cannot be extrapolated. BMJ 2002; 324(7350): 1394.
15. Ravenscroft JC, Layton A, Barnham M. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK. Clin Exp Dermatol 2000; 25(4): 327-330.
16. Stoddart B, Collyns T, Denton M. Fusidic acid cream for impetigo. Problem may be clinically important. BMJ 2002; 324(7350): 1394.
17. Sule O, Brown N, Brown DF, Burrows N. Fusidic acid cream for impetigo. Judicious use is advisable. BMJ 2002; 324(7350): 1394.
18. Weston VC, Boswell TC, Finch RG, Perkins W. Fusidic acid cream for impetigo. Emergence of resistance to fusidic acid limits its use. BMJ 2002; 324(7250): 1394.
19. Zadik P, Young N. Fusidic acid cream for impetigo. Resistance trends must be monitored. BMJ 2002; 324(7350): 1394.
20. Fleming DM, Cross KW, Barley MA. Recent changes in the prevalence of diseases presenting for health care. Br J Gen Pract 2005; 55(517): 589-595.
21. Fleming DM, Elliot AJ. Changing disease incidence: the consulting room perspective. Br J Gen Pract 2006; 56(532): 820-824.
22. Koning S, Mohammedamin RS, van der Wouden JC, et al. Impetigo: incidence and treatment in Dutch general practice in 1987 and 2001 - results from two national surveys. Br J Dermatol 2006; 154(2): 239-243.
23. Chalder M, Sharp D, Moore L, Salisbury C. Impact of NHS walk-in centres on the workload of other local healthcare providers: time series analysis. BMJ 2003; 326(7388): 532.
24. Department of Health. Up to £30 million to develop 20 fast access walk-in centres. London: Department of Health, 1999. http://www.dh.gov.uk/en/Publicationsandstatistics/Pressreleases/ DH_4025471 (accessed 22 May 2007).
25. Munro J, Sampson F, Nicholl J. The impact of NHS Direct on the demand for out-of-hours primary and emergency care. Br J Gen Pract 2005; 55(519): 790-792.
26. Salisbury C, Chalder M, Scott TM, et al. What is the role of walk-in centres in the NHS? BMJ 2002; 324(7334): 399-402.
27. Ashworth M, Latinovic R, Charlton J, et al. Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database. J Public Health 2004; 26(3): 268-274.
28. Smith S, Smith GE, Heatlie H, et al. Reducing variation in antibacterial prescribing rates for 'cough/cold' and sore throat between 1993 and 2001: regional analyses using the general practice research database. Public Health 2006; 120(8): 752-759.